The Covid-19 pandemic has disrupted the typical course of most things in our lives. Employers are facing worker shortages, high turnover, Covid prevention measures, employee burnout, impending delayed care costs and much more. Now that we are settling into the ‘new normal’, it is past time to get ‘back to basics’ with regards to getting employees and their families back to preventive and chronic care.
According to the Health Care Cost Institute (HCCI), looking at mid-year 2020 over mid-year 2019 data:
The trend continues into 2021. Key facts released from the World Health Organization show that in 2021, there were only 25 vaccine introductions other than COVID-19 vaccine and completely unvaccinated children increased by 5 million. Also, there was a global drop in vaccine coverage from 86% (2019) to 81% (2021). And girls receiving human papillomavirus (HPV) vaccinations fell by 3.5 million, compared to 2019.
While many employers have robust wellness, preventative and chronic care strategies in place, it may be time to study program data to determine if these are still applicable and effective in a post-pandemic world. Things to consider:
Finally, employers must consider the ongoing cost impact of delayed care, and what it will mean for future benefit design. There are multiple projections in the market that put healthcare trend between 4%-10% for 2023. The challenge is that many of these models do not contemplate employees coming into the healthcare system with more severe disease due to delayed or avoided care. For some employers, a few high-cost claimants could have catastrophic financial impact. In order to support our membership, IBI will produce research in 2022 on the effects of delayed care.